Logo image of JGH

NUVEEN GLOBAL HIGH INCOME (JGH) Stock Price, Quote, News and Overview

NYSE:JGH - New York Stock Exchange, Inc. - US67075G1031 - Currency: USD

12.58  -0.03 (-0.24%)

Fundamental Rating

2

JGH gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. Both the profitability and financial health of JGH have multiple concerns. JGH is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

JGH had positive earnings in the past year.
JGH had a positive operating cash flow in the past year.
In multiple years JGH reported negative net income over the last 5 years.
JGH had a positive operating cash flow in each of the past 5 years.
JGH Yearly Net Income VS EBIT VS OCF VS FCFJGH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

Industry RankSector Rank
ROA 9.17%
ROE 12.9%
ROIC 4.17%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
JGH Yearly ROA, ROE, ROICJGH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

JGH's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of JGH has declined.
JGH's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 65.49%
PM (TTM) 114.29%
GM 67.11%
OM growth 3Y-5.79%
OM growth 5Y-1.85%
PM growth 3Y16.29%
PM growth 5Y-10.88%
GM growth 3Y-6.12%
GM growth 5Y-1.93%
JGH Yearly Profit, Operating, Gross MarginsJGH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

3

2. Health

2.1 Basic Checks

There is no outstanding debt for JGH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
JGH Yearly Shares OutstandingJGH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
JGH Yearly Total Debt VS Total AssetsJGH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 1.18, we must say that JGH is in the distress zone and has some risk of bankruptcy.
JGH has a debt to FCF ratio of 4.58. This is a neutral value as JGH would need 4.58 years to pay back of all of its debts.
A Debt/Equity ratio of 0.38 indicates that JGH is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 4.58
Altman-Z 1.18
ROIC/WACCN/A
WACCN/A
JGH Yearly LT Debt VS Equity VS FCFJGH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 4.52 indicates that JGH has no problem at all paying its short term obligations.
JGH has a Quick Ratio of 4.52. This indicates that JGH is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 4.52
Quick Ratio 4.52
JGH Yearly Current Assets VS Current LiabilitesJGH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

1

3. Growth

3.1 Past

JGH shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.40%.
The earnings per share for JGH have been decreasing by -12.48% on average. This is quite bad
Looking at the last year, JGH shows a quite strong growth in Revenue. The Revenue has grown by 15.56% in the last year.
Measured over the past years, JGH shows a decrease in Revenue. The Revenue has been decreasing by -1.82% on average per year.
EPS 1Y (TTM)-4.4%
EPS 3Y21.69%
EPS 5Y-12.48%
EPS Q2Q%-12.4%
Revenue 1Y (TTM)15.56%
Revenue growth 3Y4.43%
Revenue growth 5Y-1.82%
Sales Q2Q%23.24%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JGH Yearly Revenue VS EstimatesJGH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 7.23, the valuation of JGH can be described as very cheap.
The average S&P500 Price/Earnings ratio is at 26.34. JGH is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.23
Fwd PE N/A
JGH Price Earnings VS Forward Price EarningsJGH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 11.22
EV/EBITDA N/A
JGH Per share dataJGH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.80%, JGH is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.40, JGH pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.8%

5.2 History

The dividend of JGH decreases each year by -1.46%.
JGH has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of JGH decreased recently.
Dividend Growth(5Y)-1.46%
Div Incr Years0
Div Non Decr Years1
JGH Yearly Dividends per shareJGH Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

72.50% of the earnings are spent on dividend by JGH. This is not a sustainable payout ratio.
JGH's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP72.5%
EPS Next 2YN/A
EPS Next 3YN/A
JGH Yearly Income VS Free CF VS DividendJGH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M
JGH Dividend Payout.JGH Dividend Payout, showing the Payout Ratio.JGH Dividend Payout.PayoutRetained Earnings

NUVEEN GLOBAL HIGH INCOME

NYSE:JGH (6/18/2025, 8:04:00 PM)

12.58

-0.03 (-0.24%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners41.27%
Inst Owner Change0.84%
Ins Owners0.14%
Ins Owner Change0%
Market Cap291.60M
Analysts0
Price TargetN/A
Short Float %0.08%
Short Ratio0.33
Dividend
Industry RankSector Rank
Dividend Yield 9.8%
Yearly Dividend1.26
Dividend Growth(5Y)-1.46%
DP72.5%
Div Incr Years0
Div Non Decr Years1
Ex-Date06-13 2025-06-13 (0.1035)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 7.23
Fwd PE N/A
P/S 8.33
P/FCF 11.22
P/OCF 11.22
P/B 0.94
P/tB 0.94
EV/EBITDA N/A
EPS(TTM)1.74
EY13.83%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.12
FCFY8.92%
OCF(TTM)1.12
OCFY8.92%
SpS1.51
BVpS13.37
TBVpS13.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.17%
ROE 12.9%
ROCE 5.28%
ROIC 4.17%
ROICexc 4.17%
ROICexgc 4.2%
OM 65.49%
PM (TTM) 114.29%
GM 67.11%
FCFM 74.29%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-5.79%
OM growth 5Y-1.85%
PM growth 3Y16.29%
PM growth 5Y-10.88%
GM growth 3Y-6.12%
GM growth 5Y-1.93%
F-Score5
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 4.58
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 2.89
Cash Conversion N/A
Profit Quality 65%
Current Ratio 4.52
Quick Ratio 4.52
Altman-Z 1.18
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.4%
EPS 3Y21.69%
EPS 5Y-12.48%
EPS Q2Q%-12.4%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)15.56%
Revenue growth 3Y4.43%
Revenue growth 5Y-1.82%
Sales Q2Q%23.24%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y20.63%
EBIT growth 3Y-1.61%
EBIT growth 5Y-3.64%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-25.71%
FCF growth 3Y6.18%
FCF growth 5Y-2.01%
OCF growth 1Y-25.71%
OCF growth 3Y6.18%
OCF growth 5Y-2.01%